Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments
Sepsis frequently leads to multiple organ failure and is a major cause of morbidity and mortality in critically ill patients. Although intensive care protocols and antibiotic therapy have improved sepsis treatment, specific management is lacking with respect to efficient protection from tissue damag...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Microbiology Research |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2036-7481/12/3/39 |
| _version_ | 1797528705965228032 |
|---|---|
| author | Vinicios R. dos Santos Gabriela O. de Carvalho José Bruno N. F. Silva |
| author_facet | Vinicios R. dos Santos Gabriela O. de Carvalho José Bruno N. F. Silva |
| author_sort | Vinicios R. dos Santos |
| collection | DOAJ |
| description | Sepsis frequently leads to multiple organ failure and is a major cause of morbidity and mortality in critically ill patients. Although intensive care protocols and antibiotic therapy have improved sepsis treatment, specific management is lacking with respect to efficient protection from tissue damage and long-term outcomes. Probiotics are live microbes that modulate the immune system and inflammation and colonize the gut. In this narrative review, we have traced the evolution of the administration of probiotics in an animal model of sepsis and treatment alternatives in the intensive care unit setting. First, probiotics are categorized by species before describing their modulation of the microbiota, repair of tissue-specific damage, immune response, and molecular pathways to prevent complications. The impact on therapy for infant and adult patients is also addressed. Finally, we have emphasized the challenges and gaps in current studies as well as future perspectives for further investigation. The present review can open up avenues for new strategies that employ promising probiotic strains for the treatment of sepsis and discusses their ability to prevent disease-associated long-term complications. |
| first_indexed | 2024-03-10T10:02:10Z |
| format | Article |
| id | doaj.art-f92a10a313b04bf88d1f0049c06bab84 |
| institution | Directory Open Access Journal |
| issn | 2036-7481 |
| language | English |
| last_indexed | 2024-03-10T10:02:10Z |
| publishDate | 2021-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Microbiology Research |
| spelling | doaj.art-f92a10a313b04bf88d1f0049c06bab842023-11-22T01:52:37ZengMDPI AGMicrobiology Research2036-74812021-06-0112355356610.3390/microbiolres12030039Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit EnvironmentsVinicios R. dos Santos0Gabriela O. de Carvalho1José Bruno N. F. Silva2Medicine Course, Universidade Federal do Tocantins, Palmas 77001-923, BrazilMedicine Course, Universidade Federal do Tocantins, Palmas 77001-923, BrazilMedicine Course, Universidade Federal do Tocantins, Palmas 77001-923, BrazilSepsis frequently leads to multiple organ failure and is a major cause of morbidity and mortality in critically ill patients. Although intensive care protocols and antibiotic therapy have improved sepsis treatment, specific management is lacking with respect to efficient protection from tissue damage and long-term outcomes. Probiotics are live microbes that modulate the immune system and inflammation and colonize the gut. In this narrative review, we have traced the evolution of the administration of probiotics in an animal model of sepsis and treatment alternatives in the intensive care unit setting. First, probiotics are categorized by species before describing their modulation of the microbiota, repair of tissue-specific damage, immune response, and molecular pathways to prevent complications. The impact on therapy for infant and adult patients is also addressed. Finally, we have emphasized the challenges and gaps in current studies as well as future perspectives for further investigation. The present review can open up avenues for new strategies that employ promising probiotic strains for the treatment of sepsis and discusses their ability to prevent disease-associated long-term complications.https://www.mdpi.com/2036-7481/12/3/39probioticssepsiscecal ligationcecal punctureintensive care unitmicrobiota |
| spellingShingle | Vinicios R. dos Santos Gabriela O. de Carvalho José Bruno N. F. Silva Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments Microbiology Research probiotics sepsis cecal ligation cecal puncture intensive care unit microbiota |
| title | Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments |
| title_full | Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments |
| title_fullStr | Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments |
| title_full_unstemmed | Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments |
| title_short | Probiotics for the Management of Sepsis: Advances in Animal Models and Intensive Care Unit Environments |
| title_sort | probiotics for the management of sepsis advances in animal models and intensive care unit environments |
| topic | probiotics sepsis cecal ligation cecal puncture intensive care unit microbiota |
| url | https://www.mdpi.com/2036-7481/12/3/39 |
| work_keys_str_mv | AT viniciosrdossantos probioticsforthemanagementofsepsisadvancesinanimalmodelsandintensivecareunitenvironments AT gabrielaodecarvalho probioticsforthemanagementofsepsisadvancesinanimalmodelsandintensivecareunitenvironments AT josebrunonfsilva probioticsforthemanagementofsepsisadvancesinanimalmodelsandintensivecareunitenvironments |